THYROGLOBULIN AS A TUMOR MARKER IN DIFFERENTIATED THYROID CANCER – CLINICAL CONSIDERATIONS

SUMMARY – Initial treatment of the majority of patients with differentiated thyroid cancer (DTC) includes total thyroidectomy. Postoperative ablation therapy with radioactive iodine (I-131) is indicated in all high-risk patients, however, there is disagreement regarding its use in low- and intermedi...

Descripción completa

Detalles Bibliográficos
Autores principales: Prpić, Marin, Franceschi, Maja, Romić, Matija, Jukić, Tomislav, Kusić, Zvonko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2018
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536288/
https://www.ncbi.nlm.nih.gov/pubmed/31168186
http://dx.doi.org/10.20471/acc.2018.57.03.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536288/
https://www.ncbi.nlm.nih.gov/pubmed/31168186
http://dx.doi.org/10.20471/acc.2018.57.03.16

Ejemplares similares